Terra Innovatum Global N.V. (NKLR)
NASDAQ: NKLR · Real-Time Price · USD
6.05
+0.27 (4.67%)
May 11, 2026, 10:48 AM EDT - Market open
Terra Innovatum Global Earnings Call Transcripts
Fiscal Year 2026
-
Significant progress was made in 2025, with regulatory milestones, supply chain readiness, and commercialization advancing in parallel. The SOLO microreactor program is on track for FOAK deployment in 2027, supported by $4 billion in pre-commercial commitments and a robust cash position.
Fiscal Year 2025
-
Inaugural results as a public company highlight strong funding, regulatory progress, and a robust commercialization pipeline, with NRC approval targeted for 2027 and commercial launch in 2028. Strategic partnerships and a capital-light model support rapid scaling.